Coeptis Therapeutics issues 3M shares to two investors for $3M; $500k cash, $2.5M notes due 2024

Z Squared Inc.

Issued 2.4M shares to Biofin Ventures for $2.4M ($400k cash + $2M promissory note due Aug 2024).
Issued 600k shares to AG Bio Life Capital I for $600k ($100k cash + $500k note due Aug 2024).
Notes bear 6% interest (18% on default), payable by Aug 30, 2024; investors may prepay.
If Biofin or AG sell shares before maturity, proceeds from sales must be contributed to the company.
Unregistered issuance dilutes existing shareholders by ~3M shares; only $500k received upfront.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.